---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-211050"
form_type: "8-K"
ticker: "VOR"
cik: "0001817229"
company_name: "Vor Biopharma Inc."
filed_at: "2024-08-30T23:59:59+00:00"
generated_at: "2026-05-31T06:50:17.655533+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Vor Biopharma receives Nasdaq deficiency notice for bid price below $1.00

## Summary
- Nasdaq notified Vor Biopharma on Aug 29, 2024 that its common stock bid price has been below $1.00 for 30 consecutive business days.
- Company has until Feb 25, 2025 to regain compliance by closing at or above $1.00 for at least 10 consecutive business days.
- If not compliant by Feb 2025, Vor may transfer to Nasdaq Capital Market for an additional 180-day grace period, subject to other listing requirements.
- Delisting risk exists if compliance not regained or transfer not completed; company monitoring options including potential reverse stock split.

## SEC filing metadata
- accession: 0001193125-24-211050
- form_type: 8-K
- ticker: VOR
- cik: 0001817229
- company_name: Vor Biopharma Inc.
- filed_at: 2024-08-30T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1817229/000119312524211050/0001193125-24-211050-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1817229/000119312524211050/d885644d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-211050
- JSON: https://secwatch.observer/filing/0001193125-24-211050.json
- Plain text: https://secwatch.observer/filing/0001193125-24-211050.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.